GPR119 AGONIST

摘要

A compound represented by general formula (II) or a salt thereof, which is a GPR119 agonist, is used as a therapeutic agent for diabetes. In formula (II), Ar0 represents a phenyl group or the like which may be substituted with a substituent selected from a halogen atom, a nitro group, a cyano group, a C1-8 alkyl group, and the like; R0 represents a C1-8 alkyl group; R02 represents a C1-8 alkyl group; and R04 and R05 each represent a hydrogen atom, a halogen atom, or the like.